Vipergen ApS
Gammel Kongevej 23A
1st floor
1610 Copenhagen
Denmark
VAT: DK28851758
Thank you for your interest in Vipergen, a leader in DEL based screening technologies.
Please use the contact form to reach us with any inquiries or questions. We strive to respond promptly because your communication is important to us. Thank you for your patience and understanding
Partnering with Vipergen:
Vipergen is finding tractable hits/leads for your pharmaceutical relevant targets, using three proprietary 2nd and 3rd generation DEL technologies. Vipergen is offering different business models, including simple Fee-For-Service.
Vipergen revolutionizes drug discovery by screening for novel molecules directly in living cells, providing the tool to target complex molecular entities, improve hit rates, and develop effective pharmaceuticals. Our approach prioritizes physiological relevance, ensuring a higher success rate and lower attrition rates in drug development. We excel in finding the right molecular keys for a variety of complex biological locks.
Our advanced technology allows us to conduct screenings in living cells, increasing the target space and reducing turnaround time significantly. Unlike traditional methods, our process does not require a purified version of the target protein, enabling us to handle even the most challenging targets with ease and to initiate screenings more rapidly.
Vipergen stands as a pioneer in the biotech and pharmaceutical industry, driven by a commitment to innovation and excellence. Our team of highly qualified professionals brings together extensive expertise in chemistry and biology. We are recognized for our unique ability to address complex drug discovery challenges that are beyond the reach of conventional approaches.